US Broker Ratings

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 24% Potential Upside in the Healthcare Giant

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector with a rich history dating back to 1891, offers intriguing prospects for investors looking to..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating the Prospects with a 4.25% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, captures investor interest with a robust market capitalization of $187.23 billion. As a leading..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 39% Potential Upside in Healthcare

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, is headquartered in Barcelona, Spain, and has carved out a substantial niche in the drug manufacturing..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating the 6.05% Dividend Yield and Its Implications for Investors

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector and a leading player in the global biopharmaceutical industry, continues to capture investor attention with its..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 36% Upside Potential with Robust Revenue Growth

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, stands out for its robust financial health and promising growth trajectory. Specializing in the..

Globus Medical, Inc. (GMED) Stock Analysis: Healthcare Innovator with a 31.86% Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leading player in the healthcare sector, specializes in developing advanced medical devices designed to address musculoskeletal disorders. With a market..

Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and innovative pharmaceutical advancements...

Bruker Corporation (BRKR) Stock Analysis: Insights into Potential Growth with a Market Cap of $8.91 Billion

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $8.91 billion, this..

Biogen Inc. (BIIB) Investor Outlook: Navigating Growth in the Healthcare Sector with a Potential 7.26% Upside

Biogen Inc. (NASDAQ: BIIB), a formidable player in the healthcare sector, continues to capture attention with its expansive portfolio of therapies and treatments. Based in Cambridge,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 19.81% Upside in the Medical Devices Market

GE HealthCare Technologies Inc. (NASDAQ: GEHC) stands as a pivotal player in the medical devices industry, offering a comprehensive range of products and services that spans..

Regencell Bioscience Holdings (RGC): Stock Analysis Reveals Strategic Positioning in TCM Market

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM) for neurocognitive disorders, presents an intriguing yet complex investment case in..

argenx SE (ARGX) Stock Analysis: Potential for 14% Upside Amid Robust Growth Prospects

Investors with a keen eye on the biotechnology sector should take note of argenx SE (NASDAQ: ARGX), a Netherlands-based biopharmaceutical company making significant strides in treating..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 19.66% Potential Upside Amidst Strong Analyst Support

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to capture investor attention with its robust market presence and promising growth prospects...

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings and 27.41% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) offers a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the animal health industry. With a..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 16.35% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, stands out in the biotechnology industry with its promising TransCon-based therapies. With a significant market capitalization of..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 20% Upside in the Biotech Sphere

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent name in the biotechnology sector, is catching the attention of investors with its potential for a significant upside. With..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a Potential 11.99% Upside in Bioprocessing

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $9.46 billion, this..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 25% Upside Potential in Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors in the biotechnology sector with its promising focus on metabolic dysfunction-associated steatohepatitis (MASH). The company,..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a Giant in Healthcare with Solid Revenue Growth

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, has long been a staple for investors looking for stability and consistent performance. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds